| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| R&D Expense | $332K | -18.1% |
| Operating Income | -$1.0M | +12.4% |
| Interest Expense | $39K | +0.3% |
| Income Tax | $0 | — |
| Net Income | -$1.1M | +11.3% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | +33.8% |
| Current Assets | $7K | +245.3% |
| Total Assets | $107K | +5.1% |
| Current Liabilities | $16.7M | +7.1% |
| Total Liabilities | $16.7M | +7.1% |
| Stockholders' Equity | -$16.6M | -7.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$320K | +10.8% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $321K | -30.4% |